HomeNewsBusinessUSFDA completes inspection of Dahej unit: Ajanta Pharma

USFDA completes inspection of Dahej unit: Ajanta Pharma

"Company's formulation facility at Dahej was inspected by United States Food and Drug Administration (USFDA) from April 3 to 7, 2017," Ajanta Pharma said in a filing to BSE.

April 10, 2017 / 13:42 IST
Story continues below Advertisement
Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)
Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)

Drug firm Ajanta Pharma today said the US health regulator has successfully completed inspection of its Dahej facility.

"Company's formulation facility at Dahej was inspected by United States Food and Drug Administration (USFDA) from April 3 to 7, 2017," Ajanta Pharma said in a filing to BSE.

Story continues below Advertisement

At the end of the inspection, no Form 483 was issued to the company, it added.

Form 483 is issued to a company's management after completion of inspection of its facility to notify regarding objectionable conditions.